Literature DB >> 17566743

Chimeric RNase H-competent oligonucleotides directed to the HIV-1 Rev response element.

Chrissy E Prater1, Anthony D Saleh, Maggie P Wear, Paul S Miller.   

Abstract

Chimeric oligo-2'-O-methylribonucleotides containing centrally located patches of contiguous 2'-deoxyribonucleotides and terminating in a nuclease resistant 3'-methylphosphonate internucleotide linkage were prepared. The oligonucleotides were targeted to the 3'-side of HIV Rev response element (RRE) stem-loop IIB RNA, which is adjacent to the high affinity Rev protein binding site and is critical to virus function. Thermal denaturation experiments showed that chimeric oligonucleotides form very stable duplexes with a complementary single-stranded RNA, and gel electrophoretic mobility shift assays (EMSA) showed that they bind with high affinity and specificity to RRE stem-loop II RNA (K(D) approximately 200 nM). The chimeric oligonucleotides promote RNase H-mediated hydrolysis of RRE stem-loop II RNA and have half-lives exceeding 24h when incubated in cell culture medium containing 10% fetal calf serum. One of the chimeric oligonucleotides inhibited RRE mediated expression of chloramphenicol acetyl transferase (CAT) approximately 60% at a concentration of 300 nM in HEK 293T cells co-transfected with p-RRE/CAT and p-Rev mammalian expression vectors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17566743      PMCID: PMC1987364          DOI: 10.1016/j.bmc.2007.05.066

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  44 in total

1.  Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

Authors:  R V Giles; D M Tidd
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

2.  HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA.

Authors:  D P Bartel; M L Zapp; M R Green; J W Szostak
Journal:  Cell       Date:  1991-11-01       Impact factor: 41.582

3.  Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H.

Authors:  H Inoue; Y Hayase; S Iwai; E Ohtsuka
Journal:  FEBS Lett       Date:  1987-05-11       Impact factor: 4.124

4.  A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses.

Authors:  S Y Le; M H Malim; B R Cullen; J V Maizel
Journal:  Nucleic Acids Res       Date:  1990-03-25       Impact factor: 16.971

5.  Inhibition of Rev activity and human immunodeficiency virus type 1 replication by antisense oligodeoxynucleotide phosphorothioate analogs directed against the Rev-responsive element.

Authors:  G Li; J Lisziewicz; D Sun; G Zon; S Daefler; F Wong-Staal; R C Gallo; M E Klotman
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

6.  Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines.

Authors:  R W Wagner; M D Matteucci; J G Lewis; A J Gutierrez; C Moulds; B C Froehler
Journal:  Science       Date:  1993-06-04       Impact factor: 47.728

7.  Assay for evaluating ribonuclease H-mediated degradation of RNA-antisense oligonucleotide duplexes.

Authors:  Annie Galarneau; Kyung-Lyum Min; Maria M Mangos; Masad J Damha
Journal:  Methods Mol Biol       Date:  2005

8.  Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression.

Authors:  B P Monia; E A Lesnik; C Gonzalez; W F Lima; D McGee; C J Guinosso; A M Kawasaki; P D Cook; S M Freier
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

9.  Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs.

Authors:  S Heaphy; J T Finch; M J Gait; J Karn; M Singh
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

10.  Enhanced RNase H activity with methylphosphonodiester/phosphodiester chimeric antisense oligodeoxynucleotides.

Authors:  R V Giles; D M Tidd
Journal:  Anticancer Drug Des       Date:  1992-02
View more
  4 in total

1.  Measuring cooperative Rev protein-protein interactions on Rev responsive RNA by fluorescence resonance energy transfer.

Authors:  Thomas Vercruysse; Sonalika Pawar; Wim De Borggraeve; Els Pardon; George N Pavlakis; Christophe Pannecouque; Jan Steyaert; Jan Balzarini; Dirk Daelemans
Journal:  RNA Biol       Date:  2011-03-01       Impact factor: 4.652

Review 2.  DNA and RNA derivatives to optimize distribution and delivery.

Authors:  Eric Wickstrom
Journal:  Adv Drug Deliv Rev       Date:  2015-04-22       Impact factor: 15.470

3.  Characterization and in vitro activity of a branched peptide boronic acid that interacts with HIV-1 RRE RNA.

Authors:  Jessica E Wynn; Wenyu Zhang; Denis M Tebit; Laurie R Gray; Marie-Louise Hammarskjold; David Rekosh; Webster L Santos
Journal:  Bioorg Med Chem       Date:  2016-04-05       Impact factor: 3.641

4.  Targeting folded RNA: a branched peptide boronic acid that binds to a large surface area of HIV-1 RRE RNA.

Authors:  Wenyu Zhang; David I Bryson; Jason B Crumpton; Jessica Wynn; Webster L Santos
Journal:  Org Biomol Chem       Date:  2013-10-07       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.